MARK2P6

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, MARK2P6 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MARK2P6’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MARK2P6 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MARK2P6 is over-expressed in tumor.

KIRC and KICH are the cancer types where MARK2P6 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MARK2P6 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
KIRCAllAll+0.010.0331view →
KICHAllAll+0.010.0381view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

MARK2P6–KIRC

Tumor-vs-normal expression box plot for MARK2P6 RNA in KIRC.

Open the KIRC breakdown →

Exploration